Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 800 shares, an increase of 700.0% from the June 15th total of 100 shares. Approximately 0.1% of the company’s shares are short sold. Based on […]